Advertisement
U.S. markets closed

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
16.08+0.01 (+0.06%)
At close: 04:00PM EDT
15.80 -0.28 (-1.74%)
After hours: 07:50PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
191,755
398,204
214,203
140,833
119,073
Cost of Revenue
30,546
51,967
34,393
21,884
17,039
Gross Profit
161,209
346,237
179,810
118,949
102,034
Operating Expense
77,430
259,425
77,972
66,564
60,731
Operating Income
83,779
86,812
101,838
52,385
41,303
Other Income Expense
745
7,699
2,881
282
587
Pretax Income
84,524
94,511
104,719
52,667
41,890
Tax Provision
17,607
23,101
21,640
13,185
-33,093
Net Income Common Stockholders
66,917
71,410
83,079
39,482
74,983
Diluted NI Available to Com Stockholders
66,917
71,410
83,079
39,482
74,983
Basic EPS
0.58
0.67
0.80
0.38
0.72
Diluted EPS
0.55
0.63
0.75
0.37
0.71
Basic Average Shares
105,749
106,280
103,375
103,379
103,513
Diluted Average Shares
113,925
113,753
111,376
107,796
106,242
Total Operating Income as Reported
83,779
86,812
101,838
52,385
41,303
Total Expenses
107,976
311,392
112,365
88,448
77,770
Net Income from Continuing & Discontinued Operation
66,917
71,410
83,079
39,482
74,983
Normalized Income
66,917
71,410
83,079
39,482
74,983
EBIT
83,779
86,812
101,838
52,385
41,303
EBITDA
84,436
119,693
103,077
52,577
41,395
Reconciled Cost of Revenue
30,546
51,651
34,252
21,692
17,039
Reconciled Depreciation
657
32,881
1,239
192
92
Net Income from Continuing Operation Net Minority Interest
66,917
71,410
83,079
39,482
74,983
Normalized EBITDA
84,436
119,693
103,077
52,577
41,395
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0